(Q53828672)

20 May 2018

title

Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice. (English)

1 reference

20 May 2018

1 reference

Lactobacillus reuteri

object named as

Lactobacillus reuteri

1 reference

5

1 reference

20 May 2018

Stefan Roos

object named as

S Roos

4

0 references

author name string

D Ahl

1

1 reference

20 May 2018

H Liu

2

1 reference

20 May 2018

O Schreiber

3

1 reference

20 May 2018

L Holm

6

1 reference

20 May 2018

publication date

30 April 2016

1 reference

20 May 2018

published in

Acta Physiologica

1 reference

20 May 2018

volume

217

1 reference

20 May 2018

issue

4

1 reference

20 May 2018

page(s)

300-310

1 reference

20 May 2018

Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability

cites work

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Colonic MUC2 mucin regulates the expression and antimicrobial activity of β-defensin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Secreted enteric antimicrobial activity localises to the mucus surface layer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Antimicrobial defense of the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Defining dysbiosis and its influence on host immunity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Importance and regulation of the colonic mucus barrier in a mouse model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12695

21 January 2018

Identifiers

DOI

10.1111/APHA.12695

1 reference

20 May 2018

PubMed ID

27096537

1 reference

20 May 2018